Tachibana, Masako http://orcid.org/0000-0003-4437-0065
Inada, Toshiya http://orcid.org/0000-0002-8427-5639
Ichida, Masaru
Ozaki, Norio http://orcid.org/0000-0002-7360-4898
Article History
Received: 24 January 2021
Accepted: 11 June 2021
First Online: 21 June 2021
Competing interests
: Dr. N. Ozaki has received research support or speakers’ honoraria from, or has served as a consultant to, Sumitomo Dainippon, Otsuka, DAIICHI SANKYO, Tsumura, Nihon Medi-Physics, Pfizer, KAITEKI , Eli Lilly, Mochida, Eisai, Takeda, Novartis, Astellas, MSD, Meiji Seika Pharma, Janssen, Mitsubishi Tanabe, Kyowa, Taisho Pharma, EA Pharma, UCB and Shionogi., outside the submitted work. Other authors declare no conflict of interest for the publication of this study.